GlassScriptPhysician profile
Susan Ayfer Orhan
NPI 1760496103
$2,554.84
in general payments reported to CMS, 2019-2025
34 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $282 · 2021: $363 · 2022: $791 · 2023: $408 · 2024: $332 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $326.41 | 2022-2024 | Ova1 |
| Abbvie INC. | $302.34 | 2020-2024 | |
| Coopersurgical, INC. | $225.48 | 2019-2025 | Paragard T 380a, Paragard T 380a, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Agile Therapeutics, INC. | $172.23 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $146.27 | 2020-2025 | Aptima, Acessa Provu System |
| Organon LLC | $144.09 | 2022-2025 | Nexplanon |
| Intuitive Surgical, INC. | $142.04 | 2020 | |
| Exeltis, USA INC. | $134.25 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $121.25 | 2023-2025 | |
| Avion Pharmaceuticals | $84.12 | 2020-2023 | Balcoltra |
| Millicent US INC | $71.33 | 2025 | Intrarosa, Femring, Femlyv |
| Astellas Pharma US INC | $70.38 | 2023-2024 | Veozah |
| Pfizer INC. | $64.87 | 2023-2024 | |
| Therapeuticsmd, INC. | $64.11 | 2020-2021 | |
| Biogen, INC. | $61.05 | 2025 | Zurzuvae |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $42.00 | 2019 | |
| Merck Sharp & Dohme LLC | $33.65 | 2020-2021 | |
| Ibsa Pharma INC. | $30.99 | 2023-2024 | Tirosint, Licart, Tirosint |
| Boston Scientific Corporation | $30.51 | 2019-2020 | |
| Scynexis, INC. | $29.40 | 2022 | |
| Meditrina | $28.74 | 2022 | |
| Daiichi Sankyo INC. | $26.72 | 2022 | |
| Allergan, INC. | $23.10 | 2019-2020 | |
| Gynesonics, INC. | $21.44 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $19.96 | 2021 | |
| Hologic INC | $19.63 | 2021 | |
| Pharmacosmos Therapeutics INC. | $19.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.27 | 2025 | |
| Minerva Surgical, INC | $16.55 | 2022 | |
| Bolder Surgical LLC | $15.52 | 2021 | |
| Dysis Medical, INC. | $13.59 | 2021 | |
| Monaghan Medical Corporation | $12.00 | 2023 | Aerobika |
| Acessa Health INC. | $11.71 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Orhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.